Go to content
UR Home

First-in-Human Case Study: Multipotent Adult Progenitor Cells for Immunomodulation After Liver Transplantation

URN to cite this document:
urn:nbn:de:bvb:355-epub-512289
DOI to cite this document:
10.5283/epub.51228
Soeder, Yorick ; Loss, Martin ; Johnson, Christian L. ; Hutchinson, James A. ; Haarer, Jan ; Ahrens, Norbert ; Offner, Robert ; Deans, Robert J. ; Van Bokkelen, Gil ; Geissler, Edward K. ; Schlitt, Hans J. ; Dahlke, Marc H.
[img]
Preview
PDF - Published Version
(1MB)
Date of publication of this fulltext: 21 Dec 2021 06:32



Abstract

Mesenchymal stem cells and multipotent adult progenitor cells (MAPCs) have been proposed as novel therapeutics for solid organ transplant recipients with the aim of reducing exposure to pharmacological immunosuppression and its side effects. In the present study, we describe the clinical course of the first patient of the phase I, dose-escalation safety and feasibility study, MiSOT-I (Mesenchymal ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons